Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of JAK/STAT in Interstitial Lung Diseases; Molecular and Cellular Mechanisms
Paula Montero, Javier Milara, Inés Roger, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6211-6211
Open Access | Times Cited: 178

Showing 1-25 of 178 citing articles:

Cellular mechanotransduction in health and diseases: from molecular mechanism to therapeutic targets
Xingpeng Di, Xiaoshuai Gao, Liao Peng, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 134
Traditional Chinese Medicine has great potential as candidate drugs for lung cancer: A review
Zhicheng Wei, Jing Chen, Fang Zuo, et al.
Journal of Ethnopharmacology (2022) Vol. 300, pp. 115748-115748
Closed Access | Times Cited: 71
JAK-STAT signaling in inflammation and stress-related diseases: implications for therapeutic interventions
Alexey Sarapultsev, Evgeni Gusev, Maria Komelkova, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 46
Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 revision
John A. Mackintosh, Gregory J. Keir, Lauren Troy, et al.
Respirology (2024) Vol. 29, Iss. 2, pp. 105-135
Open Access | Times Cited: 19
Role of IL-17 family cytokines in the progression of IPF from inflammation to fibrosis
Yunjuan Nie, Shuohua Wu, Ying-Hua Xuan, et al.
Military Medical Research (2022) Vol. 9, Iss. 1
Open Access | Times Cited: 57
Role of protein phosphorylation in cell signaling, disease, and the intervention therapy
Kun Pang, Wei Wang, Jiaxin Qin, et al.
MedComm (2022) Vol. 3, Iss. 4
Open Access | Times Cited: 57
The Role of IL-6 in Fibrotic Diseases: Molecular and Cellular Mechanisms
Yanxia Li, Jing Zhao, Yuan Yin, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 14, pp. 5405-5414
Open Access | Times Cited: 54
Research Progress in the Molecular Mechanisms, Therapeutic Targets, and Drug Development of Idiopathic Pulmonary Fibrosis
Hongbo Ma, Xuyi Wu, Yi Li, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 51
Canonical and noncanonical regulatory roles for JAK2 in the pathogenesis of rheumatoid arthritis‐associated interstitial lung disease and idiopathic pulmonary fibrosis
Shaohua Wang, Mengfei Liu, Xiujuan Li, et al.
The FASEB Journal (2022) Vol. 36, Iss. 6
Closed Access | Times Cited: 37
Ferulic Acid: A Review of Pharmacology, Toxicology, and Therapeutic Effects on Pulmonary Diseases
Yiman Zhai, Tingyu Wang, Yunmei Fu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8011-8011
Open Access | Times Cited: 35
Janus kinase/signal transducers and activator of transcription (JAK/STAT) and its role in Lung inflammatory disease
Manish Purohit, Gaurav Gupta, Obaid Afzal, et al.
Chemico-Biological Interactions (2023) Vol. 371, pp. 110334-110334
Closed Access | Times Cited: 29
From Infection to Death: An Overview of the Pathogenesis of Visceral Leishmaniasis
Carlos Henrique Nery Costa, Kwang-Poo Chang, Dorcas Lamounier Costa, et al.
Pathogens (2023) Vol. 12, Iss. 7, pp. 969-969
Open Access | Times Cited: 23
Mechanisms and therapeutic prospect of the JAK-STAT signaling pathway in liver cancer
Junjun Jia, Xuelian Zhou, Qingfei Chu
Molecular and Cellular Biochemistry (2024) Vol. 480, Iss. 1, pp. 1-17
Closed Access | Times Cited: 10
Crosstalk between T lymphocyte and extracellular matrix in tumor microenvironment
Die Lv, Yujie Fei, Hongli Chen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
JAK/STAT3 signaling in cardiac fibrosis: a promising therapeutic target
Heng Jiang, Junjie Yang, Tao Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 8
Exposure to the environmental pollutant chlorpyrifos induces hepatic toxicity through activation of the JAK/STAT and MAPK pathways
Huiyang Fu, Yao Ge, Xiyuan Liu, et al.
The Science of The Total Environment (2024) Vol. 928, pp. 171711-171711
Closed Access | Times Cited: 7
Insight into Janus kinases specificity: From molecular architecture to cancer therapeutics
Tian‐Hua Wei, Meng‐Yi Lu, Sihui Yao, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 7
Pirfenidone ameliorates pulmonary inflammation and fibrosis in a rat silicosis model by inhibiting macrophage polarization and JAK2/STAT3 signaling pathways
Qiong Tang, Xing Chen, Ming Li, et al.
Ecotoxicology and Environmental Safety (2022) Vol. 244, pp. 114066-114066
Open Access | Times Cited: 34
Targeting Growth Factor and Cytokine Pathways to Treat Idiopathic Pulmonary Fibrosis
Hongbo Ma, Shengming Liu, Shanrui Li, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 33
Indole-Based Small Molecules as Potential Therapeutic Agents for the Treatment of Fibrosis
Rui Qin, Qian Zhao, Bo Han, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 29
Therapeutic implications of current Janus kinase inhibitors as anti-COVID agents: A review
Nem Kumar Jain, Mukul Tailang, Hemant Kumar Jain, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 19
Four‐Arm Polymer‐Guided Formation of Curcumin‐Loaded Flower‐Like Porous Microspheres as Injectable Cell Carriers for Diabetic Wound Healing
Xiaohuan Yuan, Wei Yang, Yingying Fu, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 30
Closed Access | Times Cited: 15
Natural plant resource flavonoids as potential therapeutic drugs for pulmonary fibrosis
Meng-chuan Wang
Heliyon (2023) Vol. 9, Iss. 8, pp. e19308-e19308
Open Access | Times Cited: 15
Etiology and Pathogenesis of Rheumatoid Arthritis-Interstitial Lung Disease
Yerin Kim, Hyung-In Yang, Kyoung Soo Kim
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14509-14509
Open Access | Times Cited: 15
The current landscape of antifibrotic therapy across different organs: A systematic approach
Isabel Fuster‐Martínez, Sara Calatayud
Pharmacological Research (2024) Vol. 205, pp. 107245-107245
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top